What are the key differences in presentation, diagnostic findings, and treatment among septic encephalopathy, metabolic encephalopathy, and autoimmune encephalitis?

Comparison of Septic, Metabolic, and Autoimmune Encephalitis

The critical distinction is that encephalitis (including autoimmune) involves brain inflammation with CSF pleocytosis and/or neuroimaging abnormalities, while septic and metabolic encephalopathy represent diffuse brain dysfunction WITHOUT direct brain inflammation or infection 1.

Key Pathophysiologic Differences

Septic Encephalopathy (SAE):

• Brain dysfunction secondary to systemic sepsis without direct CNS infection 2, 3
• Mechanisms include inflammatory insults, mitochondrial dysfunction, endothelial dysfunction, and neurotransmitter disturbances 4
• No structural brain abnormality or CSF inflammation 2

Metabolic Encephalopathy:

• Brain dysfunction from systemic metabolic derangements (hypoxia, ischemia, organ failure, toxins) 5, 6
• Represents temporary or permanent disturbance without brain inflammation 5
• Most common causes: hypoxia, hepatic failure, uremia, electrolyte disorders 6

Autoimmune Encephalitis:

• True brain parenchymal inflammation from antibody-mediated mechanisms 7, 1
• Can be antibodies against surface antigens (e.g., NMDAR) or intracellular antigens (paraneoplastic) 7
• Requires evidence of inflammation: CSF pleocytosis, neuroimaging abnormalities, or pathologic confirmation 1

Clinical Presentation Distinctions

All three share altered mental status as the cardinal feature 1, but differ in:

Septic Encephalopathy:

• Delirium and coma predominate 8, 4
• Severity correlates with systemic illness severity 6
• May present with focal signs if septic-embolic/metastatic complications occur 8
• Typically reversible if sepsis controlled 6

Metabolic Encephalopathy:

• Ranges from mild confusion to deep coma 5
• Global neurological dysfunction without focal findings (unless specific etiology like hypoglycemia) 6
• Psychiatric and neurological symptoms vary by cause 5
• Generally reversible unless secondary complications develop 6

Autoimmune Encephalitis:

• Subacute onset over days to weeks (vs. acute in septic/metabolic)
• Prominent psychiatric symptoms, memory impairment, movement disorders 7
• Seizures (including faciobrachial dystonic seizures in LGI1) 7
• Severe presentations: refractory status epilepticus, dysautonomia 7

Diagnostic Algorithm

For encephalitis diagnosis, require 1:

• Major criterion: Altered mental status ≥24 hours
• Minor criteria (≥3 for probable/confirmed):
  • Fever ≥38°C within 72 hours
  • Seizures not from preexisting disorder
  • New focal neurologic findings
  • CSF WBC ≥5/mm³
  • Brain MRI abnormalities
  • EEG abnormalities consistent with encephalitis

Critical Distinction Points:

Septic Encephalopathy:

• CSF typically normal or minimal pleocytosis 2, 3
• Evidence of systemic sepsis (positive cultures, elevated inflammatory markers)
• CT/MRI may show cerebrovascular complications in persistent cases 3
• EEG shows generalized slowing, triphasic waves, but no specific pattern 3

Metabolic Encephalopathy:

• CSF normal (no pleocytosis) 6
• Metabolic derangements on laboratory testing
• Neuroimaging typically normal unless specific etiology (e.g., osmotic demyelination) 6
• EEG useful to grade severity but shows non-specific slowing 6

Autoimmune Encephalitis:

• CSF pleocytosis present (though can be absent early or in immunocompromised) 1
• Elevated CSF protein, oligoclonal bands, IgG index 7
• Neuronal autoantibodies in CSF/serum 7
• MRI abnormalities in >50% (temporal lobe, limbic system) 7
• EEG may show focal slowing, epileptiform discharges 7
• FDG-PET helpful when other studies uninformative 7

Treatment Approach

Septic Encephalopathy 8, 2, 3:

1. Identify and treat underlying infection (blood cultures, empirical antibiotics)
2. Fluid and electrolyte management
3. Maintain adequate oxygenation and blood pressure
4. Non-pharmacological delirium prevention (sleep promotion, early mobilization, cognitive stimulation) 8
5. Dexmedetomidine for sedation (preferred over midazolam due to neurotoxicity) 8, 3
6. Monitor for non-convulsive seizures 3
7. Surgery/intervention if brain abscess or mycotic aneurysm 8

• Mortality: 16-65% 5

Metabolic Encephalopathy 5, 6:

1. Treat underlying systemic illness (correct hypoxia, manage organ failure, remove toxins)
2. Supportive measures
3. Drug and metabolic screens
4. Correct electrolyte abnormalities
5. Generally reversible with treatment of underlying cause 6

• Prognosis varies by etiology (hepatic encephalopathy: <50% one-year survival) 5

Autoimmune Encephalitis 7: Once infection ruled out based on CSF, initiate immunotherapy immediately:

1. First-line: High-dose IV methylprednisolone (IVMP)

   • Exception: Use IVIG or PLEX first if:
     • Contraindications to steroids (uncontrolled hypertension/diabetes, acute peptic ulcer)
     • Severe behavioral symptoms worsening with steroids
     • High thromboembolic risk or severe hyponatremia (favor PLEX)
     • Bleeding disorders (favor IVIG)

2. If no improvement by end of initial cycle: Add IVIG or PLEX

3. Severe presentations (NMDAR encephalitis, refractory status epilepticus, dysautonomia):

   • Start combination therapy (steroids + IVIG or steroids + PLEX) immediately

4. If no improvement 2-4 weeks after first-line: Rituximab

5. Refractory cases: Consider experimental therapy (IL-6 inhibitors, bortezomib)

6. Cancer screening mandatory: CT chest/abdomen/pelvis, consider PET if negative 7

Critical Pitfalls to Avoid

1. Do not delay autoimmune encephalitis treatment waiting for antibody results - start immunotherapy once infection excluded 7

2. Avoid midazolam and cefepime in septic patients - known neurotoxic effects 3

3. CSF pleocytosis can be absent in autoimmune encephalitis (early disease, immunocompromised) - do not exclude diagnosis 1

4. Septic encephalopathy can have focal signs if septic-embolic complications - requires MRI 8, 3

5. Non-convulsive seizures common in SAE - maintain high suspicion, obtain EEG 3

6. Long-term sequelae occur in septic encephalopathy survivors - cognitive impairment, psychological disease, functional disability require surveillance 2, 3